Techniclone board duo quit
This article was originally published in Clinica
Executive Summary
US drug delivery and cancer radio-labeled therapeutics company, Techniclone, has parted company with its president and CEO Lon Stone. The move comes days after Dr Marc Lippman resigned as chief financial officer after just five months in the job.